Jubilant Pharmova Recommends Final Dividend of ₹5 Per Share for FY2025-26; Outlines TDS Guidelines
Jubilant Pharmova Limited announced that its Board of Directors has recommended a final dividend payment amounting to ₹5 per equity share for the Financial year ended March 31, 2026. This recommendation was made during a meeting held on May 22, 2026, and is subject to approval by the shareholders at the ensuing Annual General Meeting (AGM).The dividend will be paid to shareholders holding equity shares as of the record date, set for July 24, 2026. The company noted that, in compliance with the Income-tax Act, 2025, taxes must be withheld on the dividend payment. A key provision specified is that no tax will be deducted on the dividend paid to a resident individual shareholder if the total dividend received during Financial year 2026-27 does not exceed INR 10,000/-.
Tax Deductible at Source for Resident Shareholders
The company provided detailed guidance regarding the deduction of tax at source (TDS) for resident shareholders, which depends on documentation and withholding tax rates.| Sr. No. | Particular | Withholding tax rate | Declaration/documents required |
|---|---|---|---|
| 1 | Valid PAN updated in the Company's Register of Members | 10% | No document required. If the dividend does not exceed ₹10,000 for an individual Member, no TDS will be deducted. |
| 2 | No PAN or Valid PAN not updated / PAN is not linked with AADHAR (for individuals) | 20% | TDS will be deducted at 20%. For individual members, if the cumulative dividend payment exceeds ₹10,000, TDS will be deducted at 20%. |
| 3 | Availability of lower/nil tax deduction certificate from Income-Tax Department | Rate specified in the certificate | Certificate must be submitted on or before August 14, 2026. |
| 4 | Benefits under Income Tax Rule 203 | Rates based on applicability of the Income-Tax Act, 2025 | Applicable if intermediaries are not the beneficial shareholders and declaration is provided regarding the beneficial owner. |
In addition to the rates above, Nil Tax Deductible at Source (TDS) is possible for resident shareholders who submit specific documents by August 14, 2026:
| Sr. No. | Particular | Withholding tax rate | Declaration / documents required |
|---|---|---|---|
| 1 | Submission of form 121 with valid and operative PAN | NIL | Declaration in Form No. 121 fulfilling certain conditions. |
| 2 | Members covered under Section 393(1) | NIL | Valid documentary evidence for exemption. |
| 3 | Members covered under Section 393(5), such as Government or RBI | NIL | Valid documentary evidence for coverage. |
| 4 | Category I and II Alternate Investment Fund | NIL | SEBI registration certificate to claim benefit. |
| 5 | Recognised provident funds / Approved superannuation fund | NIL | Valid documentary evidence per CBDT guidelines. |
TDS Guidelines for Non-Resident Shareholders
The company detailed the withholding tax rates applicable to non-resident shareholders, requiring specific documentation by August 14, 2026, to avail beneficial rates.| Sr. No. | Category | Withholding tax rate | Declaration / documents required |
|---|---|---|---|
| 1 | Foreign Institutional Investors (FIIs)/Foreign Portfolio Investors (FPIs) | 20% (plus applicable surcharge and cess) or treaty rate, whichever is beneficial | FPI registration certificate; Tax Residency certificate; PAN or declaration as per Rule 217 of the Income-Tax Rules, 2026; E-filed Form 41. |
| 2 | Indian Branch of a Foreign Bank | NIL | Lower tax deduction certificate u/s 395(1) and self-declaration confirming income is received on its own account. |
| 3 | Availability of Lower / NIL tax deduction certificate from Income Tax Authority | Rate specified in the certificate | Certificate obtained from Income Tax Authority. |
| 4 | Any non-resident member exempted from WHT deduction | NIL | Necessary documentary evidence substantiating exemption. |
All documents related to these tax requirements, such as Form 121 or certificates, must be submitted by August 14, 2026, to determine the applicable TDS/withholding tax rate.
JUBLPHARMA Stock Price Movement
Shares of Jubilant Pharmova Limited slipped on Friday, shedding 2.36% to close at ₹935.15. The stock traded a total volume of 223,422 shares throughout the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: